Exhibit
10.21


 


CONVERTIBLE
PROMISSORY NOTE


 


NEITHER
THIS NOTE, NOR THE COMMON STOCK THIS NOTE IS CONVERTIBLE INTO, HAS, AS OF THE ISSUANCE DATE, BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR
OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL IN THE FORM, SUBSTANCE
AND SCOPE REASONABLY SATISFACTORY TO THE COMPANY, THAT THIS NOTE MAY BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF, UNDER AN
EXEMPTION FROM REGISTRATION UNDER THE ACT AND SUCH STATE SECURITIES LAWS.


 


ELECTROMEDICAL
TECHNOLOGIES, INC.


A
Delaware Corporation 


 


Convertible
Promissory Note


 


Dated:
December 11, 2019 (“Issuance Date”)


 


For
value received, Electromedical Technologies, Inc., a Delaware corporation, (the “Company”), hereby promises
to pay to Luis Michael Lu (together with his respective successors, representatives, transferees and permitted assigns,
(collectively, the “Holder”), fifty thousand dollars ($50,000.00) (the “Principal Amount”). No
interest accrues on the Principal Amount. Unless earlier converted into Conversion Shares (as defined below), the principal of
this Note will be due and payable by the Company at any time on or after May 31, 2020 (“Maturity Date”) at the Company’s
election or upon demand by the Holder.


 


All
payments under or pursuant to this Convertible Promissory Note refer to and shall be made in United States Dollars in immediately
available funds to the Holder at the address of the Holder first set forth above or at such other place as the Holder may designate
from time to time in writing to the Company or by wire transfer of funds to the Holder’s account, instructions for which
are attached hereto as Exhibit A.


 


_____________________________________


 


RECITALS


 


Company
is a corporation formed and operating in good standing under the laws of the State of Delaware. Company’s common stock is
listed on the OTC Markets listing service under the trading symbol “EMED.” On November 12, 2019, Company filed a Form
S-1 registration (the “registration”) with the U.S. Securities and Exchange Commission (“SEC”). As part
of the registration, Company will make a direct offering of ten million (10,000,000) shares of registered common stock. As
of the issuance date, the registration statement is not effective, and is subject to review, approval and the issuance of a notice
of effectiveness from the SEC. After filing the registration statement, Company received communication from the SEC that it
would review and issue comments to Company regarding the registration statement. As of the issuance date of this convertible
promissory note, Company’s registration statement is not effective.


 




    


     


    

 


ARTICLE
I


 


PAYMENT


 


Section
1.1        Payment. All payments will be made in lawful money of the United States
of America at the principal office of the Company, or at such other place as the Holder may from time to time designate in writing
to the Company. Prepayment of the principal amount may not be made without the written consent of the Holder, except in the event
of a Corporate Transaction (as set forth in Section 3.2(d).


 


ARTICLE
II


 


SECURITY


 


Section
2.1        Security. This Convertible Note is a general unsecured obligation of
the Company.


 


ARTICLE
III


 


CONVERSION


 


Section
3.1        Conversion. This Convertible Promissory Note will be convertible into
Equity Securities pursuant to the following terms.


 


Section
3.2        Definitions.


 


(a)       “Common
Stock” means the Company’s common stock, par value US $0.0001 per share.


 


(b)      “Conversion
Shares,” for purposes of determining the type of Equity Securities issuable upon conversion of this Convertible Promissory
Note, means:


 


(i)        with
respect to a conversion pursuant to Section 3.2, (a) shares of the Equity Securities eligible to be sold in the direct offering
of Company pursuant to its pending registration statement with the SEC; or (B) in the event that Company’s registration
statement is not made effective by the SEC, shares of unregistered restricted common stock;


 


(c)      “Conversion
Price,” means seventy-one cents ($0.71) per share.


 




    2


     


    

 


(d)      “Corporate
Transaction” means:


 


(i)        the
closing of the sale, transfer or other disposition, in a single transaction or series of related transactions, of all or substantially
all of the Company’s assets;


 


(ii)       the
consummation of a merger or consolidation of the Company with or into another entity (except a merger or consolidation in which
the holders of capital stock of the Company immediately prior to such merger or consolidation continue to hold a majority of the
outstanding voting securities of the capital stock of the Company or the surviving or acquiring entity immediately following the
consummation of such transaction); or


 


(iii)      the
closing of the transfer (whether by merger, consolidation or otherwise), in a single transaction or series of related transactions,
to a “person” or “group” (within the meaning of Section 13(d) and Section 14(d) of the Exchange Act),
of the Company’s capital stock if, after such closing, such person or group would become the “beneficial owner”
(as defined in Rule 13d-3 under the Exchange Act) of more than 50% of the outstanding voting securities of the Company (or the
surviving or acquiring entity).


 


For
the avoidance of doubt, a transaction will not constitute a “Corporate Transaction” if its sole purpose is to change
the state of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions
by the persons who held the Company’s securities immediately prior to such transaction. Notwithstanding the foregoing, the
sale of Equity Securities in a bona fide financing transaction will not be deemed a “Corporate Transaction.”


 


(e)       “Exchange
Act” means the Securities Exchange Act of 1934, as amended.


 


Section
3.3        Corporate Transaction Conversion. In the event of a Corporate Transaction
prior to the conversion of this Note pursuant to Section 3.2 or the repayment of this Note, at the closing of such Corporate Transaction,
the Holder may elect that either: (a) the Company will pay the Holder an amount equal to the sum of the outstanding principal
balance of this Note; or (b) this Note will convert into that number of Conversion Shares equal to the quotient (rounded down
to the nearest whole share) obtained by dividing (x) the outstanding principal balance by (y) the applicable Conversion Price.


 


Section
3.4        Maturity Conversion. At any time on or after the Maturity Date, at the
election of the Holder, this Note will convert into that number of Conversion Shares equal to the quotient (rounded down to the
nearest whole share) obtained by dividing (x) the outstanding principal balance of this Note on the date of such conversion by
(y) the Conversion Price.


 


Section
3.5        Pre-Maturity Conversion. At any time after the issuance date, at the election
of the Holder, this Convertible Promissory Note will convert into that number of Conversion Shares equal to the quotient (rounded
down to the nearest whole share) obtained by dividing (x) the outstanding principal balance of this Note on the date of such conversion
by (y) the Conversion Price.


 




    3


     


    

 


(a)      In
the event Holder elects a Pre-Maturity Conversion, and Company’s registration statement has not been made effective by the
SEC, Holder shall receive Company’s restricted common stock in an amount equal to that number of Conversion Shares equal
to the quotient (rounded down to the nearest whole share) obtained by dividing (x) the outstanding principal balance of this Note
on the date of such conversion by (y) the Conversion Price.


 


Section
3.6        Mechanics of Conversion.  Holder shall deliver to Company a copy
of this Note and a Notice of Election to Convert in the form attached hereto as Exhibit B.


 


(a)       Certificates.
As promptly as practicable after the conversion of this Note and the issuance of the Conversion Shares, the Company (at its expense)
will issue and deliver a certificate or certificates evidencing the Conversion Shares (if certificated) to the Holder, or if the
Conversion Shares are not certificated, will deliver a true and correct copy of the Company’s share register reflecting
the Conversion Shares held by the Holder. The Company will not be required to issue or deliver the Conversion Shares until the
Holder has surrendered this Note to the Company (or provided an instrument of cancellation or affidavit of loss).


 


(b)       Fractional
Shares. No fractional shares of Common Stock shall be issued upon conversion of this Note.


 


(c)       No
Impairment. The Company shall not, by amendment of its Certificate of Incorporation or through any reorganization, transfer
of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid
the observance or performance of any of the terms to be observed or performed hereunder by the Company under this Note, but will
at all times in good faith, assist in the carrying out of all the provisions of this Note, and in the taking of all such action
as may be necessary or appropriate in order to protect the Conversion Rights of the Holder against impairment.


 


(d)      Replacement.
Upon receipt of a duly executed, notarized and unsecured written statement from the Holder with respect to the loss, theft or
destruction of this Note (or any replacement hereof), and without requiring an indemnity bond or other security, or, in the case
of a mutilation of this Note, upon surrender and cancellation of such Note, the Company shall issue a new Note, of like tenor
and amount, in lieu of such lost, stolen, destroyed or mutilated Note.


 


(e)       Reservation
of Common Stock. The Company shall at all times when this Note shall be outstanding, reserve and keep available out of its
authorized but unissued Common Stock, such number of shares of Common Stock as shall from time to time be sufficient to effect
the conversion of this Note.


 


(f)       The
Company shall, from time to time in accordance with Delaware corporate law, increase the authorized number of shares of Common
Stock if at any time the unissued number of authorized shares shall not be sufficient to satisfy the Company’s obligations
under this Note.


 




    4


     


    

 


(g)      No
Rights as Shareholder. Nothing contained in this Note shall be construed as conferring upon the Holder, prior to the conversion
of this Note, the right to vote or to receive dividends or to consent or to receive notice as a shareholder in respect of any
meeting of shareholders for the election of directors of the Company or of any other matter, or any other rights as a shareholder
of the Company.


 


ARTICLE
IV


 


REPRESENTATIONS
OF THE COMPANY


 


Representations
and Warranties of the Company. In connection with the transactions contemplated by this Note, the Company hereby represents
and warrants to the Holder as follows:


 


Section
4.1       Due Organization; Qualification and Good Standing. The Company is a corporation
duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate
power and authority to carry on its business as now conducted. The Company is duly qualified to transact business and is in good
standing in each jurisdiction in which the failure to so qualify or to be in good standing would have a material adverse effect
on the Company.


 


Section
4.2        Authorization and Enforceability. Except for the authorization and issuance
of the Conversion Shares, all corporate action has been taken on the part of the Company and its officers, directors and stockholders
necessary for the authorization, execution and delivery of this Note. Except as may be limited by applicable bankruptcy, insolvency,
reorganization or similar laws relating to or affecting the enforcement of creditors’ rights, the Company has taken all
corporate action required to make all of the obligations of the Company reflected in the provisions of this Note valid and enforceable
in accordance with its terms.


 


Section
4.3        Company provided Holder with full access to all information about Company Holder
requested and considered necessary or appropriate to make an informed investment decision with respect to the Convertible Promissory
Note, and the Conversion Shares which may be acquired by Holder as a result of this Convertible Promissory Note, including reference
to all SEC filings made by Company and its audited financial statements and risk factors in its registration statement. Company
further answered all questions of Holder, and provided additional information necessary to verify any information furnished to
Holder or to which Holder had access.


 


ARTICLE
V


 


REPRESENTATIONS
OF THE HOLDER


 


Representations
and Warranties of the Holder. In connection with the transactions contemplated by this Note, the Holder hereby represents
and warrants to the Company as follows:


 




    5


     


    

 


Section
5.1        Authorization. The Holder has full power and authority (and, if an individual,
the capacity) to enter into this Note and to perform all obligations required to be performed by it hereunder. This Note, when
executed and delivered by the Holder, will constitute the Holder’s valid and legally binding obligation, enforceable in
accordance with its terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance and any other laws of general application affecting enforcement of creditors’ rights generally, and (b) as limited
by laws relating to the availability of specific performance, injunctive relief or other equitable remedies.


 


Section
5.2        Purchase Entirely for Own Account. The Holder acknowledges that this
Note is made with the Holder in reliance upon the Holder’s representation to the Company, which the Holder hereby confirms
by executing this Note, that this Note, the Conversion Shares, and any Common Stock issuable upon conversion of the Conversion
Shares (collectively, the “Securities”) will be acquired for investment for the Holder’s own account, not as
a nominee or agent (unless otherwise specified on the Holder’s signature page hereto), and not with a view to the resale
or distribution of any part thereof, and that the Holder has no present intention of selling, granting any participation in, or
otherwise distributing the same. By executing this Note, the Holder further represents that the Holder does not have any contract,
undertaking, agreement or arrangement with any person to sell, transfer or grant participations to such person or to any third
person, with respect to the Securities. If other than an individual, the Holder also represents it has not been organized solely
for the purpose of acquiring the Securities.


 


Section
5.3        Disclosure of Information; Non-Reliance. The Holder acknowledges that
he has received all the information he considers necessary or appropriate to enable him to make an informed decision concerning
an investment in the Securities. The Holder further represents that he has had an opportunity to ask questions and receive answers
from the Company regarding the terms and conditions of the offering of the Securities. The Holder confirms that the Company has
not given any guarantee or representation as to the potential success, return, effect or benefit (either legal, regulatory, tax,
financial, accounting or otherwise) of an investment in the Securities. In deciding to purchase the Securities, the Holder is
not relying on the advice or recommendations of the Company and has made his own independent decision that the investment in the
Securities is suitable and appropriate for the Holder. The Holder understands that no federal or state agency has passed upon
the merits or risks of an investment in the Securities or made any finding or determination concerning the fairness or advisability
of this investment.


 


Section
5.4        Investment Experience. The Holder is an investor in securities of companies
in the development stage and acknowledges that he is able to fend for himself, can bear the economic risk of his investment and
has such knowledge and experience in financial or business matters that he is capable of evaluating the merits and risks of the
investment in the Securities.


 


Section
5.5       Accredited Investor. The Holder is an “accredited investor” within
the meaning of Rule 501 of Regulation D promulgated under the Securities Act. The Holder agrees to furnish any additional information
requested by the Company or any of its affiliates to assure compliance with applicable U.S. federal and state securities laws
in connection with the purchase and sale of the Securities.


 




    6


     


    

 


Section
5.6        Restricted Securities. The Holder understands that the SEC has not made
Company’s registration effective as of the Issuance Date. As a result, there is material uncertainty concerning if and when
the SEC may deem the Company’s registration effective, and this may materially impact the Company’s ability to sell
registered freely tradable shares to Holder in the event Holder elects to convert prior to SEC effectiveness. In the event that
the SEC does not make Company’s registration effective, or there is a delay in obtaining SEC effectiveness, and Holder elects
to convert the principal amount due in this Note into common stock, Holder understands that he will receive “restricted
securities” under U.S. federal and applicable state securities laws and that, pursuant to these laws, the Holder must hold
the Securities indefinitely unless and until they are registered with the SEC and registered or qualified by state authorities,
or an exemption from such registration and qualification requirements is available. The Holder acknowledges that whether an exemption
from registration or qualification is available, may be conditioned on various requirements including, but not limited to, the
time and manner of sale, the holding period for the Securities, and on requirements relating to the Company which are outside
of the Holder’s control, and which the Company is under no obligation, and may not be able, to satisfy.


 


(a)       No
Public Market. The Holder understands that no public market now exists for the Securities and that the Company has made no
assurances that a public market will ever exist for the Securities.


 


(b)       No
General Solicitation. The Holder has not either directly or indirectly, including through a broker or finder, solicited offers
for or offered or sold the Securities by means of any form of general solicitation or general advertising within the meaning of
Rule 502 of Regulation D under the Securities Act or in any manner involving a public offering within the meaning of Section 4(a)(2)
of the Securities Act. The Holder acknowledges that neither the Company nor any other person offered to sell the Securities to
it by means of any form of general solicitation or advertising within the meaning of Rule 502 of Regulation D under the Securities
Act or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act.


 


(c)       Investment
Experience. Holder understands that his acquisition of the Securities involves substantial risk. Holder has experience as
an investor in securities of private companies and companies in the development stage and acknowledges that Holder is able to
fend for himself, can bear the economic risk of his investment in the Securities and has such knowledge and experience in financial
or business matters that Holder is capable of evaluating the merits and risks of this investment in the Securities and protecting
his own interests in connection with this investment.


 


(d)       Compliance
with Laws. Without in any way limiting the representations set forth above, Holder further agrees not to make any disposition
of all or any portion of the Securities, except in compliance with applicable securities laws.


 


(e)       Legend.
It is understood that the certificates evidencing the shares of restricted securities will bear a legend substantially in the
form set forth below.


 




    7


     


    

 


THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR
UNDER THE SECURITIES LAWS OF ANY OTHER JURISDICTION. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE
AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION
OR EXEMPTION THEREFROM. PURCHASERS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR
AN INDEFINITE PERIOD OF TIME.


 


(f)       Disclosure
of Information. Holder has received or has had full access to all the information Holder considers necessary or appropriate
to make an informed investment decision with respect to the Securities to be acquired by Holder as a result of this Note. Holder
further has had an opportunity to ask questions of and receive answers from the management of Company regarding the Securities,
and to obtain additional information necessary to verify any information furnished to Holder or to which Holder had access. Further,
Holder has undertaken its own review of the business of Company and the wisdom of an investment in the Company Securities. Holder
has had the opportunity to review all of the books, records and all SEC filings of Company, including all Company audited financial
statements, financial disclosures and risk factors that Company has published concerning its operations. Holder acknowledges being
knowledgeable about companies in the development stage, and the risk factors associated with such companies.


 


ARTICLE
VI


 


MISCELLANEOUS


 


Section
6.1       Successors and Assigns. Except as otherwise provided herein, the terms and
conditions of this Note will inure to the benefit of, and be binding upon, the respective successors and assigns of the parties;
provided, however, that the Company may not assign its obligations under this Note without the written consent of the Holder.
This Note is for the sole benefit of the parties hereto and their respective successors and permitted assigns, and nothing herein,
express or implied, is intended to or will confer upon any other person or entity any legal or equitable right, benefit or remedy
of any nature whatsoever under or by reason of this Note.


 


Section
6.2       Choice of Law. This Note, and all matters arising out of or relating to this
Note, whether sounding in contract, tort, or statute will be governed by and construed in accordance with the internal laws of
the State of Delaware, without giving effect to the conflict of laws provisions thereof to the extent such principles or rules
would require or permit the application of the laws of any jurisdiction other than those of the State of Delaware.


 


Section
6.3       Counterparts. This Note may be executed in counterparts, each of which will
be deemed an original, but all of which together will be deemed to be one and the same agreement. Counterparts may be delivered
via facsimile, electronic mail (including PDF or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g.,
www.docusign.com) or other transmission method, and any counterpart so delivered will be deemed to have been duly and validly
delivered and be valid and effective for all purposes.


  




    8


     


    

 


Section
6.4        Titles and Subtitles. The titles and subtitles used in this Note are
included for convenience only and are not to be considered in construing or interpreting this Note.


 


Section
6.5       Notices. All notices and other communications given or made pursuant hereto
will be in writing and will be deemed effectively given: (a) upon personal delivery to the party to be notified; (b) when sent
by email or confirmed facsimile; (c) five (5) days after having been sent by registered or certified mail, return receipt requested,
postage prepaid; or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery,
with written verification of receipt. All communications will be sent to the respective parties at the addresses shown on the
signature pages hereto (or to such email address, facsimile number or other address as subsequently modified by written notice
given in accordance with this Section 6.5).


 


Section
6.6       No Finder’s Fee. Each party represents that it neither is nor will be
obligated to pay any finder’s fee, broker’s fee or commission in connection with the transactions contemplated by
this Note. The Holder agrees to indemnify and to hold the Company harmless from any liability for any commission or compensation
in the nature of a finder’s or broker’s fee arising out of the transactions contemplated by this Note (and the costs
and expenses of defending against such liability or asserted liability) for which the Holder or any of its officers, employees
or representatives is responsible. The Company agrees to indemnify and hold the Holder harmless from any liability for any commission
or compensation in the nature of a finder’s or broker’s fee arising out of the transactions contemplated by this Note
(and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers,
employees or representatives is responsible.


 


Section
6.7       Attorneys’ Fees. If any action at law or in equity is necessary to enforce
or interpret the terms of this Note, the prevailing party will be entitled to reasonable attorneys’ fees, costs and necessary
disbursements in addition to any other relief to which such party may be entitled.


 


Section
6.8       Entire Agreement; Amendments and Waivers. This Note constitutes the full and
entire understanding and agreement between the parties with regard to the subject hereof. Any term of this Note may be amended
and the observance of any term may be waived (either generally or in a particular instance and either retroactively or prospectively)
with the written consent of the Company and the Holder. Any waiver or amendment effected in accordance with this Section 6.8 will
be binding upon each future holder of this Note and the Company.


 


Section
6.9       Severability. If one or more provisions of this Note are held to be unenforceable
under applicable law, such provisions will be excluded from this Note and the balance of the Note will be interpreted as if such
provisions were so excluded and this Note will be enforceable in accordance with its terms.


 




    9


     


    

 


Section
6.10     Acknowledgment. For the avoidance of doubt, it is acknowledged that the Holder will be
entitled to the benefit of all adjustments in the number of shares of the Company’s capital stock as a result of any splits,
recapitalizations, combinations or other similar transactions affecting the Company’s capital stock underlying the Conversion
Shares that occur prior to the conversion of this Note.


 


Section
6.11     Further Assurances. From time to time, the parties will execute and deliver such additional
documents and will provide such additional information as may reasonably be required to carry out the terms of this Note and any
agreements executed in connection herewith.


 


Section
6.12      Officers and Directors not Liable. In no event will any officer or director of
the Company be liable for any amounts due and payable pursuant to this Note.


 


Section
6.13     Approval. The Company hereby represents that its board of directors, in the exercise
of its fiduciary duty, has approved the Company’s execution of this Note based upon a reasonable belief that the principal
provided hereunder is appropriate for the Company after reasonable inquiry concerning the Company’s financing objectives
and financial situation. In addition, the Company hereby represents that it intends to use the principal of this Note primarily
for the operations of its business, and not for any personal, family or household purpose.


 


Section
6.14      Waiver of Jury Trial. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL
OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS NOTE, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF.
THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE
TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE),
BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES
HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER REPRESENTS AND WARRANTS THAT
SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL
RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.


  




    10


     


    

 


	 	Dated: December 11, 2019	 
	 	 	 
	 	Luis Lu [HOLDER]	 
	 	 	 
	 	By:	/s/
    Luis Michael Lu	 
	 	 	 
	 	 	 	Luis Michael Lu	 
	 	 	 
	 	 	 	4480 S Rosemary Place	 
	 	 	 	Chandler, AZ 85248	 
	 	 	 	814-335-5274	 
	 	 	 	mdeyes203@hotmail.com	 


 


	 	ELECTROMEDICAL TECHNOLOGIES,
    INC.
	 	 
	 	By:	 
	 	 
	 	 	 	Matthew N. Wolfson
	 	 
	 	 	 	President, Chief Executive Officer
	 	 
	 	 	 	Electromedical Technologies, Inc.
	 	 	 	16561 N 92ND Street, Suite 101
	 	 	 	Scottsdale, AZ 85260
	 	 	 	Email: ceo@electromedtech.com
	 	 	 	Attention: Mr. Matthew Wolfson


 






    11